A February executive order on pharmaceutical price transparency does nothing to change the incentives that keep costs opaque. But drug companies and other stakeholders would reap the benefits of such ...

Treatment of PG is currently limited to immune-suppressing drugs and antibiotics to treat complicating infections and, in ...

The president said that, because of his executive order, prescription drug prices would be cut “almost immediately.” Here's ...

Discussion around international reference pricing (IRP) is intensifying as policymakers search for ways to address persistently high prescription drug costs in the United States. With news of the ...

Commercialization building with large pharma contracts secured Further progress on next generation sequencing assays for DNA ...

Shares in iTeos Therapeutics surged after the company said it would wind down operations. The stock was up 27% at $10.87 in premarket trading. Shares were already up 11% year-to-date when the market ...

R&D spending across the global pharmaceutical sector climbed 1.5% in 2024, according to unreleased data from Evaluate Pharma.

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company formerly known as BeiGene, Ltd., today announced its new name and redomiciliation to Switzerland are officially ...

With thousands of gene and cell therapies in the pipeline, health systems should make sure they are for these drugs, which can cost millions per dose, according to the American Society of ...

McDermott gathered more than 100 health and life sciences innovators, investors, business leaders and advisers in Paris for our ...

This designation is meaningful as it signifies our continued commitment to making biosimilars more accessible. Both biosimilars and interchangeable biosimilars are highly similar and have no ...

From housing to immigration, here's everything King Charles III said during his speech from the throne, which was delivered ...